Leonid Metelitsa CD1-MR1 Workshop 2025

Abstracts this author is presenting:

• Cancer Immunotherapy with CAR-Redirected NKT Cells — Therapy of Cancer and Other Diseases 1
• Allogeneic NKT Cells Expressing a CD19-specific CAR in Patients with Relapsed or Refractory B cell Malignancies: an Interim Analysis — Poster Session 1